Healthcare >> CEO Interviews >> February 15, 2005

Martin Mattingly – Cancervax Corporation (cnvx)

MARTIN A. MATTINGLY is Executive Vice President, Marketing and Business Development of CancerVax Corporation. Dr. Mattingly has served as Executive Vice President, Marketing and Business Development since May 2003. From May 1996 to May 2003, Dr. Mattingly worked at Agouron Pharmaceuticals, a Pfizer company, where he held various management positions including Vice President, General Manager for the Agouron division; Vice President, Product Development Group at Pfizer's New York headquarters; Vice President, Global Marketing Planning; Senior Director of Marketing; and Director of Product Marketing. From October 1983 to May 1996, Dr. Mattingly worked at Eli Lilly and Co. where he held various management positions in oncology marketing and sales management. Dr. Mattingly holds a Doctor of Pharmacy degree from the University of Kentucky. Profile
TWST: Would you begin with a brief historical sketch of CancerVax and a

picture of what you are doing at the present time?

Mr. Mattingly: CancerVax is a biotech company that is focused on